A method for integrating patient-reported outcomes for patients with primary mitochondrial disease

日本 ニュース ニュース

A method for integrating patient-reported outcomes for patients with primary mitochondrial disease
日本 最新ニュース,日本 見出し
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

Researchers from the Mitochondrial Medicine Program at Children's Hospital of Philadelphia (CHOP) developed a new method of capturing patient and caregiver reported outcomes that can be readily integrated with clinical information from the electronic medical record to provide important information that helps guide tailored treatment strategies.

A method for integrating patient-reported outcomes for patients with primary mitochondrial disease retrieved 28 March 2024 from https://medicalxpress.com/news/2024-03-method-patient-outcomes-patients-primary.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.4 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

medical_xpress /  🏆 101. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Study reveals trigonelline as a therapeutic agent for mitochondrial dysfunction in agingStudy reveals trigonelline as a therapeutic agent for mitochondrial dysfunction in agingSarcopenia is the age-related decline in skeletal muscle due to the wasting of myofiber.
続きを読む »

Mitochondrial DNA fragment losses predict Parkinson's disease before symptoms appearMitochondrial DNA fragment losses predict Parkinson's disease before symptoms appearThe survival of neurons, unlike most other cells in the body, depends largely on the energy provided by mitochondria, intracellular organelles that contain their DNA to function properly.
続きを読む »

Newly discovered beneficial mutation in mitochondrial DNA seems to help Alzheimer's gene carriers live longerNewly discovered beneficial mutation in mitochondrial DNA seems to help Alzheimer's gene carriers live longerResearchers at the USC Leonard Davis School of Gerontology have discovered a genetic mutation in a small mitochondrial protein that may promote longevity, preserve cognitive function, and protect against Alzheimer's disease among carriers of APOE4, a gene associated with a dramatic increase in the risk of developing Alzheimer's disease.
続きを読む »

Role in mitochondrial metabolism paints more complete picture of MCL-1 functionRole in mitochondrial metabolism paints more complete picture of MCL-1 functionThe life and death of cells are governed by processes that—when disrupted—can lead to cancer. Apoptosis, the process of programmed cell death, is tightly regulated by the B-cell lymphoma-2 (BCL-2) family of proteins. This includes myeloid cell leukemia-1 (MCL-1), an anti-apoptotic protein that helps cells stay alive.
続きを読む »

Unveiling mitochondrial mysteries to conquering cancer therapy resistanceUnveiling mitochondrial mysteries to conquering cancer therapy resistanceNational University of Singapore (NUS) scientists have discovered that the evasion of apoptosis is a key driver of drug resistance in patients with relapsed acute myeloid leukemia (AML), a type of aggressive blood cancer. The results are expected to contribute towards the identification of effective drugs for treating relapsed patients.
続きを読む »

Researchers forge new path to combat viruses and cancers with helicase inhibitorsResearchers forge new path to combat viruses and cancers with helicase inhibitorsHelicases are enzymes that unwind DNA and RNA. They're central to cellular life, implicated in a number of cancers and infections-;and, alas, extraordinarily difficult to target with drugs.
続きを読む »



Render Time: 2025-04-13 06:06:20